Follow-The-Filings

Manager activity

Merck & Co., Inc.

2026 Q2 vs 2026 Q1 · filed 7 Aug · all filings · sitewide activity

New 3
Exit 4

moves

7 shown

ticker action Δ port detail period
Entrada Therapeutics New +2.43 pp opened 2.4% Q1→Q2
Sutro Biopharma New +1.72 pp opened 1.7% Q1→Q2
Evaxion Biotech New +0.71 pp opened 0.7% Q1→Q2
Entrada Therapeutics Exit −6.28 pp was 6.3% Q1→Q2
Sutro Biopharma Exit −1.94 pp was 1.9% Q1→Q2
Evaxion Biotech Exit −1.29 pp was 1.3% Q1→Q2
Carisma Therapeutics Exit −0.01 pp was 0.01% Q1→Q2